Genmab | GEN - 流动资产





流动资产 更改 日
Agios Pharmaceuticals USD 717.67M 117.18M 2026-06
Almirall EUR 747.1M 33.12M 2026-06
Amarin USD 602.76M 23.26M 2026-06
Amgen USD 31.48B 2.42B 2026-03
argenx SE USD 8.07B 1.17B 2026-06
AstraZeneca USD 27.97B 1.65B 2026-06
Bayer EUR 35.3B 2.39B 2026-03
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Demant DKK 10.08B 128M 2025-12
Exelixis USD 1.21B 234.65M 2026-03
Fresenius Medical Care EUR 8.11B 209.55M 2026-03
Genmab DKK 2.88B 1.59B 2025-12
GlaxoSmithKline GBP 17.56B 202M 2026-06
GN Store Nord DKK 4.85B 3.79B 2026-03
GRIFOLS EUR 5.25B 180M 2026-03
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Insmed USD 1.61B 181.04M 2026-03
Lakefront Biotherapeutics EUR 3.06B 18.72M 2026-03
Lonza CHF 8B 3.41B 2025-12
Merck EUR 14.16B 932M 2026-03
Novartis USD 27.35B 744M 2026-06
Regeneron Pharmaceuticals USD 18.45B 236.8M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
UCB EUR 6.05B 733M 2025-12